Page results
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
Please be advised that from 1 October 2021, the management of the Queen Square private consulting rooms (PCR) will be transferring from Queen Square Enterprises to UCLH Private Healthcare. This means that both private inpatient and outpatient facilities at the National Hospital for Neurology and Neurosurgery (NHNN) will now be managed by the private arm of UCLH NHS Foundation Trust.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
File results
-
-
-
-
-
-
-
Issue 19 - UCLH Magazine 2023
-